No profile data available.
Perrigo Company plc (PRGO) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Dublin, Ireland, with about 8,100 full-time employees.
It reported revenue of $4.25 billion for fiscal year 2025, down 2.8% from fiscal year 2024, and net income of -$1.43 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $1.02 billion, down 3.2% from a year before. Its largest business segment, Consumer Self-Care Americas, brought in 61% of segment revenue in fiscal year 2025; United States was the largest region with 60%. Its market capitalization was $2.09 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments.
Perrigo reported $4.25 billion in revenue for fiscal year 2025, down 2.8% from $4.37 billion in fiscal year 2024. In Q2 2026 revenue was $1.02 billion.
Consumer Self-Care Americas, with $2.59 billion or 61% of segment revenue in fiscal year 2025. Next: Consumer Self-Care International (39%).
United States: 60% of revenue by region in fiscal year 2025, followed by Europe (37%).
$2.09 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Nurix Therapeutics, Inc. (NRIX), Prestige Consumer Healthcare Inc. (PBH), Bausch Health Companies Inc. (BHC), Intellia Therapeutics, Inc. (NTLA).